Organic Chemistry TRIZ Cases

Bonded light absorbers prevent solvent elution in temporary semiconductor adhesives.

This case combines silica with bentonite or sepiolite to stabilize powdered propandiol mononitrate and support accurate dosage.

This case uses substituted tetrahydroquinoline compounds to inhibit IDO, modulate tryptophan metabolism, and support T-cell activation.

This case uses sulfonic acid anions and tertiary ammonium cations to improve pot life, dispersion, hardness, and water resistance.

Sharpless dihydroxylation and Suzuki coupling enable scalable chiral pyridone synthesis without wasteful separation.

This case uses ambient-condition molecular sieve adsorption to lower water in propylene oxide while preserving chemical integrity.

A solventless two-component polyurethane adhesive uses epoxy-aromatic diisocyanate and phosphate ester polyol to strengthen metal bonding.

Specific heteroaryl structures improve LTA4H inhibition while supporting lipoxin A4 biosynthesis for inflammation resolution.

Formula 1 and 2 host materials lower OLED deposition temperature while preserving charge transport.

Specific branched trisamide structures nucleate polyolefin crystallization, reducing haze and limiting additive extraction.

This case uses heterocyclic compounds to lower RBP4 levels while balancing dose, efficacy, and side-effect risk.

Hydrolysis creates soluble, hydroxylated polymer fragments from thermosets, enabling reprocessing and material upcycling.

This case uses alkali metal acetate and acid hydrolysis at mild temperature to produce the target compound at 89–91% yield.

This case uses Formula I compounds to target HDAC subtypes, reactivate latent HIV, and reduce adverse effects during cART.

This case uses Pirfenidone or PEG-Pirfenidone to modulate B-cell activity and protect organs after acute injury.

Dihydrobenzimidazolones bind cereblon to alter substrate specificity and degrade target proteins.

This case uses thermally stable spirobifluorene structures to transport holes and balance OLED lifetime, efficiency, and voltage.

This case develops propionic acid derivatives that selectively inhibit integrin α4β7 while avoiding significant hERG and CYP inhibition.

This case uses radical-quenching, radiation-absorbing compounds to preserve nucleic acid integrity and sequencing signal quality.

This case uses oil-soluble melamine derivatives to limit copper leaching and tarnishing while fitting lubricant formulations.

This route converts a nitro-N-oxide precursor to 4-amino-5-methylpyridone with 84% overall yield and no chromatography.

Novel xanthene fluorophores support PALM live-cell imaging with 28–37 nm localization precision, without chemical additives.

Polyethyleneamine salts of sulphonyl oleic acid address ULSD conductivity loss and lubricity decline while improving additive stability.

Peptoid inhibitors mimic histone H4 while resisting proteolysis for selective PRMT1 and PRMT5 inhibition and cancer-cell apoptosis.

A C8 splitter and optional p-xylene recovery subsystem produce high-octane AvGas components without tetraethyl lead.

This case uses inorganic carbonate, CO2, heat, and agitation to produce FDCA while simplifying processing and reducing solvent use.

Direct tumor injection uses capsazepine derivatives to block TRPV1, reduce tumor volume, and prevent invasion of critical structures.

This case uses defined substituent patterns in Kv3 modulator compounds to balance channel selectivity, in vivo potency, and safety.

See how trisamide derivatives nucleate polyolefin crystallization to reduce haze and limit extraction in food-contact and medical uses.

Mannitol-derived structural units and controlled copolymer ratios raise thermal performance for practical polycarbonate applications.

Selective THR agonists lower lipids while limiting cardiovascular and thyroid-axis effects.

This case uses neutral amide derivatives for passive mitochondrial targeting, low cytotoxicity, and long-term photostable imaging.

Substituted macrocyclic ligands balance Fe(III) complex stability, redox resistance, and high relaxivity for MRI contrast.

Host-dopant energy tuning enables TADF emission with higher efficiency and longer device life.

Localized substitution and chalcogen atoms support soluble, stable films with excellent carrier mobility for organic thin-film transistors.

This case uses modular anthranilic acid scaffolds to diversify Pin1 inhibitors for inflammatory disease and cancer therapy.

This case uses low-ΔEST TADF compounds to harvest triplet energy and extend blue-light OLED emission lifetime.

This case uses metal-ion interactions in CYP11B2 inhibitors to reduce aldosterone without direct MR-antagonist side effects.

Molecular tuning and composite donor-acceptor structures improve NIR harvesting and charge transport in semi-transparent OPVs.

This case uses meso carbic anhydride, enantioselective ring opening, ozonolysis, and reduction to produce a high-purity P2 ligand.

This case uses targeting ligands and linkers to recruit the Cul3-based E3 ligase for KEAP1-mediated aberrant protein degradation.

This case develops THRβ-selective compounds that preserve agonist activity while limiting cardiac effects and thyroid axis inhibition.

Multiple Gd chelates amplify MR signal, while small PSMA-targeted compounds support rapid-clearance imaging and radiotherapy.

NRRP chalcone compounds potentiate estradiol without direct estrogen-receptor agonism.

Delayed fluorescence from fused polycyclic compounds improves OLED efficiency, lowers driving voltage, and extends service life.

This case balances isocyanurate and uretdione groups to improve coating workability, drying speed, and film hardness.

A photosensitive initiator enables direct quantum dot patterning without photoresist.

A modular Apalutamide process replaces hazardous reagents with safer solvents to improve yield, purity, cost, and polymorph stability.

Benzoyl-pyrazine OLED compounds use voltage variation to tune narrow emission colors, reducing the need for multiple sub-pixels.

This case uses multi-point Formula I binding to inhibit the conserved cap-dependent endonuclease for broader influenza protection.

Segmented isobaric and mass differential labeling reagents generate unique reporter ions for precise analyte identification.

Benzimidazole derivatives activate NOD2 and TLR7/8 receptors to enhance vaccine adjuvantic effects.

A polymeric pigment dispersant uses aromatic anchoring blocks to stabilize particles through pi-pi interactions.

N-substituted diphenethylamine derivatives act as kappa opioid receptor partial agonists to separate analgesic efficacy from neuropsychiatric side effects.

Pyridazinone-based prodrugs achieve metabolic benefits via selective TR-beta activation while minimizing cardiovascular toxicity from TR-alpha stimulation.

A polymerizable sulfonium salt generates acid and participates in photoresist polymerization to define precise lithographic patterns.

A supramolecular complex immobilizes flavorant compounds via non-covalent host-guest association to enable controlled release during consumption.

Formula I and II compounds bind SIRT3 to control deacylation activity, addressing unclear mechanisms in mitochondrial metabolism.

Small molecule compounds induce mesenchymal stem cell differentiation into chondrocytes via TGF-beta signaling pathways.

Composite organic compounds with expanded LUMO levels balance hole and electron mobility, resolving electrochemical stability limits to extend device lifespan.

Selective 5-HT2A receptor ligands improve binding affinity to overcome placebo limitations in treating drug-resistant depression.

A deuterated phosphodiesterase type-5 inhibitor modifies metabolic stability to deliver controlled therapeutic duration.

Novel indanyloxydihydrobenzofuranylacetic acids activate the GPR40 receptor to enhance insulin secretion.

Minimized singlet-triplet energy splitting in TADF compounds reduces degradation rates from high-energy excitation, extending blue OLED lifetime.

Glycerol acts as an intermediary additive to depress the dimethyl sulfoxide freezing point without causing demixing or reducing stripping efficiency.

Specific chemical compounds inhibit Aurora kinase activity to arrest cell cycling and promote apoptosis in cancer cells.

Metal salt additives enhance charge injection in organic semiconducting materials.

A bicyclic sulfate-based electrolyte additive forms a durable modified layer on lithium battery electrodes to stabilize the solid electrolyte interface.

A rupatadine derivative with a carbonyl group achieves high water solubility, enabling aqueous liquid formulations.

Fused benzoxazole rings in the compound reduce driving voltage, resolving the trade-off between high efficiency and limited operational lifespan.

Decomposing acidic compounds reduces acidity to change resist solubility, resolving sensitivity versus pattern fidelity trade-offs in lithography.

Tricyclic substituted piperidine dione compounds modulate the CRBN protein to down-regulate IKZF3 levels.

Extranuclear-selective estrogen receptor ligands activate metabolic pathways while reducing reproductive tissue stimulation.

A fluorine-containing ether compound forms a lubricating layer on magnetic recording media to reduce friction between the head and surface.

Heterocyclic compounds enhance electron transport, resolving electrochemical stability limits for large displays.

Small molecule pyrimidinones replace unstable peptides to improve APJ agonist potency and stability for heart failure treatment.

Reducing sulfonic acid concentration in the polyanion copolymer minimizes moisture absorption and leakage current while maintaining high conductivity.

A solid phase mixture containing periodic acid and silica gel selectively oxidizes interfering 1,2-diol compounds during extraction.

A triazine-dibenzofuran compound with carbazole moieties balances electron and hole transport in organic optoelectronic devices.

Oligo-benzamide peptidomimetics block AR-PELP-1 interaction to resolve peptide stability trade-offs while inhibiting prostate cancer cell proliferation.

Compounds inhibit ROCK kinases at the ATP binding site, reducing metastatic potential in cancer cells.

Synthesizes CO2-based polyester polymers through ring-opening polymerization of cyclic lactones using organic base catalysts.

Bioorthogonal molecules trigger rapid leaving group release upon tetrazine interaction.

A one-step method synthesizes 3-spiro three-membered ring indolinone derivatives using NBS or NCS with an organic base.

Hydrogel particles with affinity dye compounds capture and stabilize low abundance serum proteins, improving detection sensitivity.

Pyrrolopyrimidine compounds activate Toll-like receptor 7 to stimulate innate immunity.

A distillation column control system varies the reflux ratio and proactively adjusts energy input based on feed stream conditions.

Heating Form I to 203°C with seed crystals produces Form II, resolving bulk density limitations for pharmaceutical processing.

Microwave-synthesized styryl quinolinium probes stain nucleoli with high photostability, resolving synthesis complexity and stability trade-offs.

2-Aminopyridine derivatives inhibit neuronal nitric oxide synthase while evading P-glycoprotein efflux to improve brain exposure.

A near-infrared cut filter combines absorption and reflection layers to maintain spectral transmittance across varying incidence angles.

A triazine-based organic compound dopant enhances hole injection properties in OLED auxiliary layers.

A tertiary amine compound stabilizes the hole transport layer internal resistance to maintain photoelectric conversion efficiency.

Methotrexate analogs recruit E3 ligases to degrade DHFR, bypassing resistance from polyglutamylation and mutations.

Segmenting synthesis into monofunctional intermediates reduces manufacturing complexity while maintaining therapeutic efficacy.

Optimized biphenyl structure resolves selectivity trade-off, delivering strong LSD1 inhibition for cancer therapy.

Sulfonate and isocyanate electrolyte additives form stable solid electrolyte interface films on electrode surfaces.